Hey there! This post may contain affiliate links. As an Amazon Associate, I earn a teensy commission from qualifying purchases when you buy through these links (at no additional cost to you). For more info, please check the full disclaimer.
A new study conducted by researchers from the University of Nottingham has found that menopausal hormone therapy (MHT), commonly known as hormone replacement therapy (HRT), is not linked to an increased risk of dementia, regardless of hormone type, dose or duration of use.
The study also found that women under 80 taking estrogen-only therapy for 10 years or more had a decreased risk of dementia.
However, long-term users of estrogen-progestogen therapies had a slightly increased risk of developing Alzheimer’s disease.
The study’s findings could have implications for women considering hormone therapy to manage symptoms of menopause. They advise women should consult their doctors to weigh the benefits and risks of medicinal hormone balance before starting it.